graying of hair canities HIRSUIT G2B Chromafendâ„¢ Flaxseed extract Linum usitatissimum Graying of hair Canities Melanocyte Melanocyte stem cell Melanin
Conditions
Interventions
HAIRSUIT G2B will be applied twice daily (morning and evening) on both sides of the temporal area.
Experimental Drug
HAIRSUIT G2B
Sponsors
Dermatology division, Department of internal medicine, King Chulalongkorn Memorial Hospital
Dermatology division,
Department of internal medicine,
King Chulalongkorn Memorial Hospital
Eligibility
Sex/Gender
Male
Age
30 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. male participants age 30-40 year 2. no history of hair dye within 3 months prior to the study 3. the participant who is willing to attain the project 4. the participant who can follow the instruction and is able to visit the study site
Exclusion criteria
Exclusion criteria: 1. the volunteer who uses product or medication that affects hair color within 3 months prior to the study 2. the participant who wants to dye his hair 3. the participant who is allergic to the ingredient in HAIRSUIT G2B 4. the participant who has skin disease or infection on the scalp 5. the participant who is on the immunosuppressive medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the ratio of number of white hair to number of black hair week 0,4,8,12 number of hair count/foto finder | — |
Secondary
| Measure | Time frame |
|---|---|
| Color Measuring week 0,4,8,12 CIE L*a*b* ,clinical grading of graying of hair severity week 0,4,8,12 Visual analogue scale (VAS) | — |
Countries
Thailand
Contacts
Public ContactRatchathorn Panchaprateep
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed